Rare diseases
Investigational molecules
Locations
Back to Spain445 clinical trials in Galdakao, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainStudy Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment
SpainStudy on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer
SpainStudy on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant
SpainStudy on the Safety and Effectiveness of MK-1942 for Patients with Mild to Moderate Alzheimer's Disease
SpainStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
SpainStudy of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy
SpainStudy on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease
SpainStudy on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy
SpainStudy on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia
SpainStudy of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Breast Cancer Resistant to Trastuzumab, Pertuzumab, and Taxane Treatment
SpainStudy Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on breast cancer treatments, including trials for HER2-positive and triple-negative variants. Research encompasses innovative therapies for pancreatic adenocarcinoma and colon cancer.
Multiple trials evaluating novel drug combinations and targeted therapies for improved patient outcomes.
Comprehensive research into pulmonary fibrosis and respiratory conditions, with studies examining new treatments for COPD and pulmonary embolism management.
Innovative approaches to improve lung function and patient quality of life.
Investigations into cardiomyopathy prevention and treatment, including trials for acute coronary syndromes and peripheral arterial disease management.
Focus on preventive strategies and improved treatment protocols for heart conditions.
Studies addressing endocrine disorders, including hypothyroidism and its effects. Research on hepatic conditions and smoking cessation therapies.
Diverse therapeutic approaches targeting various medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
